We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.05%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$7.04B
AUM Growth
-$1.16B
Cap. Flow
-$1.24B
Cap. Flow %
-17.66%
Top 10 Hldgs %
20.16%
Holding
1,770
New
124
Increased
619
Reduced
705
Closed
247

Sector Composition

Rank Sector Weight
1 Technology 19.04%
2 Financials 9.47%
3 Industrials 8.13%
4 Communication Services 7.76%
5 Healthcare 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPA icon
1151
Copa Holdings
CPA
$5.76B
$407K 0.01%
3,376
-108
-3% -$13.2K
BSJR icon
1152
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$857M
$406K 0.01%
17,975
+2,486
+16% +$56.3K
REGL icon
1153
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.75B
$406K 0.01%
4,819
-177
-4% -$14.9K
CYBR
1154
DELISTED
CyberArk
CYBR
$405K 0.01%
909
-226
-20% -$109K
SLNO
1155
DELISTED
Soleno Therapeutics
SLNO
$405K 0.01%
8,747
-101
-1% -$5.54K
AGNC icon
1156
AGNC Investment
AGNC
$12.4B
$403K 0.01%
37,608
-86
-0.2% -$884
STK
1157
Columbia Seligman Premium Technology Growth Fund
STK
$867M
$403K 0.01%
10,947
+820
+8% +$30.1K
VTS icon
1158
Vitesse Energy
VTS
$651M
$400K 0.01%
20,776
+530
+3% +$11.3K
DHS icon
1159
WisdomTree US High Dividend Fund
DHS
$1.56B
$398K 0.01%
+3,908
New +$394K
URGN icon
1160
UroGen Pharma
URGN
$1.86B
$397K 0.01%
+16,962
New +$368K
FTGS icon
1161
First Trust Growth Strength ETF
FTGS
$1.29B
$396K 0.01%
11,200
-150
-1% -$5.33K
XYLD icon
1162
Global X S&P 500 Covered Call ETF
XYLD
$3.24B
$394K 0.01%
9,685
+2,833
+41% +$113K
IYF icon
1163
iShares US Financials ETF
IYF
$4.67B
$393K 0.01%
3,049
RLTY icon
1164
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$266M
$393K 0.01%
26,729
RUN icon
1165
Sunrun
RUN
$2.34B
$393K 0.01%
21,344
-1,000
-4% -$19.2K
MSA icon
1166
Mine Safety
MSA
$7.35B
$392K 0.01%
2,450
STIP icon
1167
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$391K 0.01%
3,822
+1,067
+39% +$110K
PNW icon
1168
Pinnacle West Capital
PNW
$12.2B
$391K 0.01%
4,410
-298
-6% -$26.7K
EVLV icon
1169
Evolv Technologies
EVLV
$995M
$390K 0.01%
54,512
+3,000
+6% +$21.3K
IGOV icon
1170
iShares International Treasury Bond ETF
IGOV
$1.53B
$389K 0.01%
9,328
SUN icon
1171
Sunoco
SUN
$14.4B
$388K 0.01%
7,396
-70
-0.9% -$3.7K
JRI icon
1172
Nuveen Real Asset Income & Growth Fund
JRI
$356M
$387K 0.01%
28,454
-6,797
-19% -$93.4K
NNE
1173
Nano Nuclear Energy
NNE
$854M
$385K 0.01%
+16,044
New +$614K
ALNY icon
1174
Alnylam Pharmaceuticals
ALNY
$27.5B
$384K 0.01%
966
-750
-44% -$332K
SPHY icon
1175
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.5B
$384K 0.01%
16,218
-10,444
-39% -$248K

Similar funds

Oppenheimer & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Oppenheimer & Co held 1,770 positions worth $7.04B, down 14% from $8.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co withdrew a net $1.24B in Q4 2025, closing 247 positions and reducing 705 holdings. Its most notable exit was Apple, an estimated $286M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

Against the trend, Oppenheimer & Co opened a new position in First Trust Nasdaq Bank ETF worth $4.47M.

  • Oppenheimer & Co's largest Q4 2025 buy was First Trust Nasdaq Bank ETF: 118,163 shares worth $4.47M.
  • Oppenheimer & Co added most to iShares Russell 1000 Growth ETF in Q4 2025, an estimated $21.1M increase.
  • Oppenheimer & Co's biggest Q4 2025 reduction was ServiceTitan Inc, cutting an estimated $49.2M.
  • Oppenheimer & Co fully exited Apple in Q4 2025, selling an estimated $286M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $7.04B portfolio in Q4 2025.
  • Oppenheimer & Co opened 124 new positions and closed 247 in Q4 2025.
  • Oppenheimer & Co's portfolio value fell 14% quarter-over-quarter to $7.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2025, filed 2 Feb 2026.